HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.

Abstract
Imidazolium trans-imidazoledimethylsulphoxidetrachlororuthenate (NAMI-A) was tested in vitro on the pro-adhesive properties, evaluated as resistance to trypsin treatment, which is a bona fide measure of adhesion strength, of KB and HeLa carcinoma cell lines and on human polymorphonuclear neutrophils (HPMN). NAMI-A increased the pro-adhesive activity of KB cells at 0.001 mM concentration, after few minutes incubation and this effect was not influenced by the vehicle used for cell challenge, neither did it depend on NAMI-A concentration or on temperature. The same effect occurred on HeLa cells at 0.01 mM NAMI-A. This effect, detected at concentrations up to 100 times lower than those necessary to block cells at the G(2)-M premitotic phase of cell cycle, or to inhibit matrix metalloproteinase release or cell invasion, was not related to ruthenium uptake by tumour cells. HeLa cells and healthy HPMN, following short exposure to 0.1 mM NAMI-A, assumed a different shape, with the extrusion of filopodia (HeLa) and of large lamellopodia (HPMN), which increased their interactions with the substrate. This effect was attributed to stabilisation, altered turnover and sensitivity to cytochalasin D of actin filaments. Provided that adhesion is associated with cell motility and invasion, these data suggest that NAMI-A may exert antimetastatic properties at concentrations lower than those observed in the lungs at the end of a conventional intraperitoneal treatment in vivo.
AuthorsG Sava, F Frausin, M Cocchietto, F Vita, E Podda, P Spessotto, A Furlani, V Scarcia, G Zabucchi
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 40 Issue 9 Pg. 1383-96 (Jun 2004) ISSN: 0959-8049 [Print] England
PMID15177498 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Blocking
  • Antineoplastic Agents
  • Integrins
  • Organometallic Compounds
  • Ruthenium Compounds
  • imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)
  • Ruthenium
  • Trypsin
  • Dimethyl Sulfoxide
Topics
  • Actin Cytoskeleton (drug effects, ultrastructure)
  • Antibodies, Blocking (pharmacology)
  • Antineoplastic Agents (analysis, pharmacology)
  • Cell Adhesion (drug effects)
  • Cell Line
  • Dimethyl Sulfoxide (analogs & derivatives, analysis, pharmacology)
  • HeLa Cells
  • Humans
  • Integrins (immunology)
  • Microscopy, Confocal
  • Microscopy, Electron, Scanning
  • Neoplasms (drug therapy, pathology)
  • Neutrophils (chemistry, drug effects, ultrastructure)
  • Organometallic Compounds (analysis, pharmacology)
  • Ruthenium (analysis)
  • Ruthenium Compounds
  • Trypsin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: